Stress hormone biomarkers and cognitive functions among HIV-positive patients with opioid use disorder

Abstract

Aim – to investigate the role of the detoxification-associated stress on cognitive functions during early remission among HIV-positive patients with opioid use disorder.

Material and methods. Prospective cohort study among HIV-positive patients with opioid use disorder (n=41) who admitted at the hospital for detoxification due to opioid withdrawal syndrome. Participants were assessed at four visits: Visit 0 – at hospital admission (Day 0); Visit 1 – the peak of withdrawal (Days 3–5); Visit 2 – at the end of detoxification therapy (Day 10–14) and Visit 3 – early remission (Days 21–40). We applied experimental psychological and clinical psychopathological methods, also laboratory assessment of plasma cortisol, dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) levels was conducted.

Results. The level of cortisol in plasma was elevated while DHEA-S level was decreased during whole period of observation. The intensity of cognitive impairment were gradually decreased over 3 weeks after detoxification compared to withdrawal treatment period (p<0.05). In regression model we found that increased ratio of cortisol to DHEA during withdrawal was associated with severe cognitive deficits during remission [regression coefficient (95% CI) = -1.2 (-2; -0.4)].

Conclusion. Our funding shown that cognitive impairment, including decreased information proceeding speed, learning and memory in HIV-positive patients remain during several weeks after opioid detoxification treatment. The study results suggested the hypothalamic pituitary adrenal system dysfunction which activated by the cessation of opioid use and withdrawal. We conclude that the neuroendocrine system was involved in the development of cognitive impairment in HIV-positive patients during opioid withdrawal syndrome.

Keywords:HIV; cognition; opioid; substance use disorder; stress; dehydroepiandrosterone

Funding. The research is financially supported by the research grant from Russian Science Foundation, #20-15-00049, 2020.

Conflict of interest. The authors declare that there is no conflict of interest.

Contribution. The concept and design of the study – Krupitsky E.M., Zvartau E.E., Blokhina E.A.; collection and processing of material – Vetrova M.V., Palatkin V.Ya., Toussova O.V., Protsenko E.A., Borovskaya V.G., Irkhina M.D., Belova O.G.; statistical processing – Vetrova M.V.; writing the text – Vetrova M.V., Palatkin V.Ya., Protsenko E.A., Borovskaya V.G., Irkhina M.D., Belova O.G.; editors – Toussova O.V., Blokhina E.A., Kholodnaia A.N., Lioznov D.A., Krupitsky E.M.

For citation: Vetrova M.V., Palatkin V.Ya., Protsenko E.A., Borovskaya V.G., Irkhina M.D., Belova O.G., Toussova O.V., Blokhina E.A., Bushara N.M., Yaroslavtseva T.S., Kholodnaia A.N., Lioznov D.A., Krupitsky E M., Zvartau E.E. Stress hormone biomarkers and cognitive functions among HIV-positive patients with opioid use disorder. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2022; 11 (3): 112–9. DOI: https://doi.org/10.33029/2305-3496-2022-11-3-112-119

References

1. Federal Scientific and Methodological Center for the Prevention and Control of AIDS FBUN of the Central Research Institute of Epidemiology of Rospotrebnadzor. Reference. HIV infection in the Russian Federation in 2017. (in Russian)

2. State Anti-Drug Committee. Report on the drug situation in the Russian Federation in 2018 (excerpt). 2019. (in Russian)

3. Yakovlev A.A., Diachkov A.G., Musatov V.B.,, Strelyanaya E.V., Mikitenko E.V., Gorodnicheva L.R. Prevalence rate and impact of addictive disorders on the course of Hiv-infection in in-patients. Epidemiologiya i infektsionnye bolezni [Epidemiology and Infectious Diseases]. 2017; 22 (6): 281–8. DOI: https://doi.org/10.18821/1560-9529-2017-22-6-281-288 (in Russian)

4. Petrosyan T.R., Shakhmardanov M.Z. HIV-infection and consumption of psychoactive substances. Epidemiologiya i infektsionnye bolezni [Epidemiology and Infectious Diseases]. 2018l; 23 (1): 60–7. DOI: https://doi.org/10.18821/1560-9529-2018-23-2-60-67 (in Russian)

5. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 2008; 1141: 105–30. DOI: https://doi.org/doi:10.1196/annals.1441.030

6. Woolley C.S., Gould E., McEwen B.S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 1990; 531 (1–2): 225–31. DOI: https://doi.org/10.1016/0006-8993(90)90778-A

7. Brunner R., Schaefer D., Hess K., Parzer P., Resch F., Schwab S. Effect of corticosteroids on short-term and long-term memory. Neurology. 2005; 64: 335–8. DOI: https://doi.org/10.1212/01.WNL.0000149523.35039.4C

8. Maninger N., Wolkowitz O.M., Reus V.I., Epel E.S., Mellon S.H. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol. 2009; 30 (1): 65–91. DOI: https://doi.org/10.1016/j.yfrne.2008.11.002

9. Dong Y., Zheng P. Dehydroepiandrosterone sulphate: action and mechanism in the brain. J Neuroendocrinol. 2012; 24 (1): 215–24. DOI: https://doi.org/10.1111/j.1365-2826.2011.02256.x

10. Christeff N., Gherbi N., Mammes O., Dalle M.T., Gharakhanian S., Lortholary O., et al. Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology. 1997; 22 (1): S11–8. DOI: https://doi.org/10.1016/S0306-4530(97)00015-2

11. Aggarwal J., Taneja R.S., Gupta P.K., Wali M., Chitkara A., Jamal A. Sex hormone profile in human immunodeficiency virus-infected men and it’s correlation with CD4 cell counts. Indian J Endocrinol Metab. 2018; 22: 328–34. DOI: https://doi.org/10.4103/ijem.IJEM_694_17

12. Wesson D.R., Ling W. The clinical opiate withdrawal scale (COWS). J Psychoactive Drugs. 2003; 35 (2): 253–9. DOI: https://doi.org/10.1080/02791072.2003.10400007

13. Heaton R.K., Marcotte T.D., Rivera Mindt M., Sadek J., Moore D.J., Bentley H., et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004; 10 (3): 317–31. DOI: https://doi.org/10.1017/S1355617704102130

14. Bryun E.A., Guekht A.B., Polunina A.G., Davydov D.M. Premorbid neuropsychological status in heroin abusers: impact on tolerance growth and treatment compliance. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Journal of Neurology and Psychiatry named after S.S. Korsakov]. 2002; 102 (6): 21–9. (in Russian)

15. Agibalova T.V., Poplevchenkov K.N. The state of cognitive functions in opiate addicted patients. Voprosy narkologii [Problems of Narcology]. 2012; (4): 62–73. (in Russian)

16. Kuznetsova O.A., Petrikov D.A. Structure and severity of cognitive changes in HIV-infected inpatients treated at AIDS Center. VICH infektsiya i immunosupressii [HIV Infection and Immunosuppression]. 2013; 5 (2): 52–7. (in Russian)

17. Vetlugina T.P., Nikitina V.B., Lobacheva O.A., Mandel A.I., Lyashenko G.P., Roshchina O.V. Cortisol and testosterone levels in alcoholic patients in withdrawal syndrome. Sibirskiy vestnik psikhiatrii i narkologii [Siberian Bulletin of Psychiatry and Narcology]. 2017; 3 (96): 5–10. (in Russian)

18. Gamaleya N.B. Immunotherapy for narcological diseases (part II). Voprosy narkologii [Problems of Narcology]. 2012; (1): 84–112. (in Russian)

19. Facchinetti F., Volpe A., Farci G., Petraglia F., Porro C.A., Barbieri G., et al. Hypothalamus-pituitary-adrenal axis of heroin addicts. Drug Alcohol Depend. 1985; 15 (4): 361–6. DOI: https://doi.org/10.1016/0376-8716(85)90014-6

20. Kreek M.J., Wardlaw S.L., Hartman N., Raghunath J., Friedman J., Schneider B., et al. Circadian rhythms and levels of β-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans. Life Sci. 1983; 33: 409–11. DOI: https://doi.org/10.1016/0024-3205(83)90529-5

21. Katamanova E.V., Rukavishnikov V.S., Lakhman O.L., Shevchenko O.I., Denisova I.A. Cognitive impairment in a toxic lesion of the brain. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Journal of Neurology and Psychiatry named after S.S. Korsakov]. 2015; 115 (2): 11–5. DOI: https://doi.org/10.17116/jnevro20151152111-15 (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)

Journals of «GEOTAR-Media»